These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 14283247)

  • 1. THE TREATMENT OF BLADDER TUMORS BY THE INTRAVESICAL INSTILLATION OF THIO-TEPA OR OF ACTINOMYCIN D.
    ESQUIVEL EL
    Acta Med Philipp; 1965; 1():124-6. PubMed ID: 14283247
    [No Abstract]   [Full Text] [Related]  

  • 2. THE TREATMENT OF BLADDER TUMORS BY THE INTRAVESICAL INSTILLATION OF THIO-TEPA OR OF ACTINOMYCIN D.
    ESQUIVEL EL
    Philipp J Surg Surg Spec; 1964; 19():332-7. PubMed ID: 14260308
    [No Abstract]   [Full Text] [Related]  

  • 3. TREATMENT OF BLADDER TUMORS BY INSTILLATION OF THIO-TEPA, ACTINOMYCIN D, OR 5-FLUOROURACIL.
    ESQUIVEL EL; MACKENZIE AR; WHITMORE WF
    Invest Urol; 1965 Jan; 2():381-6. PubMed ID: 14260865
    [No Abstract]   [Full Text] [Related]  

  • 4. 32p-labeled thio-tepa absorption in normal rat bladders: potential guide for intravesical chemotherapy in bladder cancer.
    Puchner PJ; Veenema RJ; Tomashefsky P; Pinzus T; Tannenbaum T
    Urology; 1974 Jul; 4(1):33-6. PubMed ID: 21322979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of intravesical instillation of Thio-Tepa on the recurrence rate of bladder tumors.
    Asahi T; Matsumura Y; Tanahashi T; Yoshimoto J; Kaneshige T; Fujita Y; Ohmori H
    Acta Med Okayama; 1980 Feb; 34(1):43-9. PubMed ID: 6446839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A longitudinal study of patients with superficial bladder carcinoma successfully treated with weekly intravesical thio-tepa.
    Nocks BN; Nieh PT; Prout GR
    J Urol; 1979 Jul; 122(1):27-9. PubMed ID: 110947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intravesical application of thio-tepa for preventing postoperative recurrence of bladder carcinoma].
    Zhang SX; Deng XZ; Tang XD
    Zhonghua Wai Ke Za Zhi; 1986 Aug; 24(8):486-7, 510. PubMed ID: 3102180
    [No Abstract]   [Full Text] [Related]  

  • 8. The prophylactic use of thio-tepa and urokinase in transitional cell carcinoma of the bladder: a preliminary report.
    Hisazumi H; Uchibayashi T; Naito K; Misaki T; Miyazaki K
    J Urol; 1975 Sep; 114(3):394-8. PubMed ID: 806708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravesical thio-tepa: a study of 3H-thymidine uptake in normal urothelium and FANFT-induced tumors in rats.
    Nieh PT; Daly JJ; Irwin RJ; Prout GR
    Invest Urol; 1979 May; 16(6):486-8. PubMed ID: 109416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [THE PRACTITIONER AND ANTINEOPLASTIC CHEMOTHERAPY. RECENT DATA].
    RAVINA A
    Presse Med (1893); 1965 Jan; 73():287-90. PubMed ID: 14230318
    [No Abstract]   [Full Text] [Related]  

  • 11. [Intravesical chemotherapy for superficial bladder tumors].
    Ohmori H
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1557-62. PubMed ID: 6206797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic effect of triethylenethiophosphoramide on the recurrence rate of superficial bladder tumors.
    Mukamel E; Zitron S; Nissenkorn I; Servadio C
    Isr J Med Sci; 1980; 16(9-10):714-6. PubMed ID: 6776072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bladder carcinoma treated by direct instillation of thio-TEPA.
    VEENEMA RJ; DEAN AL; ROBERTS M; FINGERHUT B; CHOWHURY BK; TARASSOLY H
    J Urol; 1962 Jul; 88():60-3. PubMed ID: 13925166
    [No Abstract]   [Full Text] [Related]  

  • 14. The cytological effect of chemicals on tumors. XI. Effects of thio-TEPA and actinomycin-C on normal and neoplastic cells in vitro.
    AWA A
    Gan; 1961 Mar; 52():49-55. PubMed ID: 13685307
    [No Abstract]   [Full Text] [Related]  

  • 15. [Preliminary results of a randomized study between intravesical adriamycin and thio-tepa in the treatment of superficial tumors of bladder].
    Allona Moncada A; Santos García Vaquero I; Polo Villar G; Díaz González R; González Martín M; Zuloaga Gómez A; Martínez Torres JL; Rodríguez Alvarez J; Duarte Vázquez JJ; Megino López JF
    Arch Esp Urol; 1984; 37(2):113-22. PubMed ID: 6431914
    [No Abstract]   [Full Text] [Related]  

  • 16. ThioTEPA pharmacokinetics during intravesical chemotherapy: the influence of dose and volume of instillate on systemic uptake and dose rate to the tumour.
    Masters JR; McDermott BJ; Harland S; Bibby MC; Loadman PM
    Cancer Chemother Pharmacol; 1996; 38(1):59-64. PubMed ID: 8603453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphologic effects of thio-TEPA on mouse urothelium.
    Murphy WM; Soloway MS; Lin CJ
    Acta Cytol; 1977; 21(5):701-4. PubMed ID: 414498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prophylactic use of Thio-TEPA, an adjuvant in the treatment of bladder tumours.
    Dobrzecki W; Kaczmarek A
    Int Urol Nephrol; 1977; 9(2):145-9. PubMed ID: 412808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Severe bone marrow damage after instillation of thio tepa into the bladder].
    Edgren B; Forsgren L; Boström H
    Nord Med; 1966 Apr; 75(17):481. PubMed ID: 4956156
    [No Abstract]   [Full Text] [Related]  

  • 20. [Depression of bone marrow after intravesical use of Thio-tepa].
    Malling N
    Ugeskr Laeger; 1980 Sep; 142(40):2630-1. PubMed ID: 6777928
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.